PURPOSE. Effects of cis-unoprostone isopropyl, its primary metabolite M1, trans-unoprostone isopropyl, latanoprost free acid, and fluprostenol were studied on Ca 2þ -activated K þ (BK) channels, plasma membrane potential, [cAMP] i , [cGMP] i , and steady state [Ca 2þ ] i , and protection against endothelin-1 (ET-1)-induced steady state [Ca 2þ ] i increases in human cortical neuronal (HCN-1A), trabecular meshwork (HTMC), and pulmonary artery smooth muscle (PASMC) cells. Effects on recombinant human prostaglandin (PG) receptors were determined.
PURPOSE. Effects of cis-unoprostone isopropyl, its primary metabolite M1, trans-unoprostone isopropyl, latanoprost free acid, and fluprostenol were studied on Ca 2þ -activated K þ (BK) channels, plasma membrane potential, [cAMP] i , [cGMP] i , and steady state [Ca 2þ ] i , and protection against endothelin-1 (ET-1)-induced steady state [Ca 2þ ] i increases in human cortical neuronal (HCN-1A), trabecular meshwork (HTMC), and pulmonary artery smooth muscle (PASMC) cells. Effects on recombinant human prostaglandin (PG) receptors were determined.
METHODS. BK channel currents were measured using whole-cell patch clamp; [cAMP] i , [cGMP] i with ELISAs; [Ca 2þ ] i with indo-1; plasma membrane potential using diBAC 4 ] i increases. Trans-unoprostone isopropyl had no effects. Unoprostone isopropyl (1.25 lM) had no effect on PG receptors, and neither did M1, except for activating the FP receptor with EC 50 ¼ 557.9 6 55.2 nM (n ¼ 4). T he aim of this study was to determine the molecular and cellular effects of the IOP-lowering antiglaucoma agent, cisunoprostone isopropyl (UF-021 1, 2 ) and its primary metabolite M1, the de-esterified form lacking the isopropyl group 3 (i.e., unoprostone free acid). As was previously demonstrated, unoprostone isopropyl is a potent activator of iberiotoxin (IbTX)-sensitive Ca 2þ and voltage-activated K þ channels (maxi K þ or BK channels), causes plasma membrane hyperpolarization, does not increase steady state [Ca 2þ ] i , and counteracts the effects of glutamate-dependent [Ca 2þ ] i deregulation in human cortical neuronal cells (HCN-1A). 4 From this study and others, 4, 5 unoprostone isopropyl is thought to have neuroprotective properties. Neuroprotection has been directly shown in preclinical studies on photoreceptor/ganglion cell survival. 6 Unoprostone isopropyl's mechanism of action was distinct from that of PGF 2a (which does not activate BK channels) 7 and latanoprost, a PGF 2a analog. BK channels are present in trabecular meshwork cells and their activation increases outflow facility and decreases cell volume. 8, 9 Many studies point to a significant involvement of the potent vasoconstrictor endothelin-1 (ET-1) in the pathophysiology of glaucoma and other ocular diseases. 10, 11 ET-1 has been shown to contract the trabecular meshwork, 8 reduce choroidal blood flow via contraction of vascular smooth muscle cells, 12 and to have neurotoxic effects. 13, 14 Consequently, compounds functionally antagonizing ET-1 effects are viewed as potential IOPlowering and neuroprotective agents. 10 Indeed, a human study 15 and a recent study using a nonhuman primate glaucoma model 16 showed effective IOP lowering following ET-1 receptor blockade. It has been previously demonstrated that M1 activated BK channel currents in trabecular meshwork cells (TMCs), inhibited ET-1-induced contractions, and inhibited ET-1-induced [Ca 2þ ] i increases in TMC and ciliary muscle strips. 8 In the present studies, effects of unoprostone isopropyl and M1 (both cis forms of the drug) were compared and contrasted with effects of trans-unoprostone isopropyl, which does not lower IOP (Ueno R, personal written communication, 2011), to determine if the effects of unoprostone isopropyl and M1 were stereospecific. HCN1-A cells express BK channel currents and channel protein, 4, 17, 18 and were used by numerous investigators to study BK channels and to study unoprostone isopropyl effects. 4 Therefore, only effects of unoprostone isopropyl's primary metabolite M1 were studied in HCN-1A cells. Effects of unoprostone isopropyl and M1 on BK channels were measured in human trabecular meshwork cells (HTMCs) and pulmonary artery smooth muscle cells (PASMCs). Because unoprostone isopropyl (Rescula) is used for reducing IOP in ocular hypertension and glaucoma 1, 5, 19, 20 by increasing blood flow 12, 21, 22 and aqueous humor (ocular) outflow facility, 23 HTMCs were used in the present study as a particularly relevant ocular cell model. BK channels are the predominant K þ channels present in vascular smooth muscle, 24 and when they are activated, result in plasma membrane hyperpolarization ultimately causing vasodilation. 25, 26 PASMCs were used for studying BK channel activity in vascular smooth muscle. 27, 28 There is some controversy as to whether unoprostone isopropyl and M1 are prostaglandin (PG) receptor agonists. 4, 29, 30 Therefore, direct measurement of unoprostone isopropyl and M1 agonist effects on recombinant human PG (EP 1 -EP 4 and FP) receptors, was carried out to determine whether the prostones, unoprostone isopropyl and M1, are agonists of these receptors. The affinities were then compared with the dose response for BK channel activation.
CONCLUSIONS. Prostones
PGF 2a and PGF 2a -based antiglaucoma agents increased steady state [Ca 2þ ] i in HCN-1A cells, whereas unoprostone isopropyl did not. 4 In [Ca 2þ ] i increases were also examined. These effects were compared with effects of the PGF 2a analogs, latanoprost free acid and fluprostenol (travoprost free acid), which are the active forms of latanoprost and travoprost. 34 Unoprostone isopropyl, latanoprost, and travoprost are all isopropyl esters that are hydrolyzed to the active forms, the free acids. 35 
MATERIALS AND METHODS

Materials
Hank's balanced salt solution (HBSS) 6 phenol red, 6 Ca 2þ was from Invitrogen (Carlsbad, CA). Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), and HCN-1A cells were from ATCC (Manassas, VA). HTMCs and Fibroblast medium were from ScienCell Research Laboratories (Carlsbad, CA). Human PASMCs and SMGM-2 BulletKit (smooth muscle basal medium plus growth factors) were from Lonza (Walkersville, MD). Valinomycin, bis-(1,3-diethylthiobarbituric acid) trimethine oxonol (DiBAC 4 [3] ) and the acetoxymethyl ester (AM) of indo-1 (indo-1/AM), from Molecular Probes (Eugene, OR), were dissolved in ethanol. Latanoprost free acid and fluprostenol (travoprost free acid) were from Cayman Chemical Co (Ann Arbor, MI). Unopro-
, M1 (unoprostone free acid), and trans-unoprostone isopropyl (trans isomer of unoprostone isopropyl) were from R-Tech Ueno, Ltd. (Sanda, Japan), provided as frozen aliquots of 10-mM solutions in 100% dimethyl sulfoxide (DMSO). In HCN-1A experiments, DMSO was the diluent, 0.1% final DMSO concentration. In all other experiments, 100% ethanol was the diluent to reduce DMSO final concentration to 0.00001%. Vehicle controls were always carried out. IbTX from Tocris Cookson (Ellisville, MO) was dissolved in water. AL-8810 (11 beta-fluoro-15-epiindanyl PGF 2a ) and ionomycin (SigmaAldrich, St. Louis, MO) were dissolved in DMSO and ethanol respectively. ET-1 (Calbiochem, La Jolla, CA) was dissolved in 5% acetic acid. The Parameter cAMP kit was from R & D Systems (Minneapolis, MN) and the Direct cGMP EIA kit was from Enzo Life Sciences (Farmingdale, NY).
Cell Culture
HCN-1A cells (passage 4) were grown in DMEM medium with 10% FBS to 85% to 90% confluence on 9 3 22-mm glass cover slips and 35-mm Petri dishes as described previously. 4 HTMC were grown in poly-Llysine-coated flasks in the recommended defined Fibroblast medium containing 2% FBS and then seeded onto poly-L-lysine-coated 35-mm Petri dishes and glass coverslips for experiments. Cell passages 2 to 10 (of 15 guaranteed by the company) were used. PASMCs (passages 1 and 2) were grown in defined smooth muscle cell culture medium on 9 3 22-mm glass coverslips or in 35-mm Petri dishes.
Patch Clamp Measurement of Whole-Cell BK Currents
Whole-cell patch clamp measurement of K þ currents was carried out as previously described. 4 Borosilicate glass pipettes were pulled by a 2-stage Narashige puller (Narishige International, USA, Inc., East Meadow [Long Island], NY) to produce 1.0-to 1.5-M X resistance. Data were acquired with an Axopatch CV-4 headstage (Molecular Devices, Sunnyvale, CA), a Digidata 1200 digitizer (Molecular Devices), and an Axopatch 1D amplifier (Molecular Devices). Sampling frequency was 1 KHz, filter setting was 1 KHz, and seal resistances were 10 G X. Data were analyzed using pClamp 6.04 (Axon Instruments, Union City, CA), Excel, and Origin 5 (OriginLab, Northampton, MA).
Measurement of Plasma Membrane Potential
Plasma membrane potential was determined as described. 4 Cells grown on coverslips were incubated with 100 nM DiBAC 4 (3) in HBSS for 5 minutes in the dark. Experimental procedures including calibration were as described. 4 ] i determination were as described. 4 
Measurement of [cAMP] i , [cGMP] i , and Steady
Measurement of Prostaglandin Receptor Activity
Unoprostone isopropyl and M1 agonist effects on human cloned recombinant EP [1] [2] [3] [4] and FP receptors were assayed by Millipore Corporation, Bioscience Division (St. Charles, MO), using ChemiScreen Ca 2þ -Optimized GPCR Stable Cell Lines expressing EP 1 , EP 2 , EP 3 , EP 4 , and FP receptors and a fluorometric imaging plate reader (FLIPR) fluo-4 fluorescent assay of [Ca 2þ ] i changes. This method 36, 37 has been used for a variety of receptors. 38 These GPCR cell lines containing high levels of the promiscuous G protein, Ga15, to enhance coupling of the receptor to the calcium signaling pathway, were transfected with cDNAs of either full-length human EP 1 , EP 2 , splice variant 6 of EP 3 , EP 4 , and FP receptors. Using fluo-4 fluorescent assays of [Ca 2þ ] i changes, agonist effects of unoprostone isopropyl and M1 were measured using the various cell lines with the respective recombinant prostaglandin receptors. Results were expressed in relative fluorescence units and plotted as % maximum response. PGE 2 and PGF 2a were used as positive controls for EP and FP receptors respectively.
Statistical Analysis
Statistical significance was determined using Student's t-test. Origin 5 (OriginLab, Northampton, MA) was used to fit curves. The number of independent experiments (n) and P values for statistical significance are indicated on graphs, in legends, and in the text. For BK current measurements, n is the number of cells patched. For plasma membrane potential and [Ca 2þ ] i measurements, n is the number of coverslips used. For all other experiments, n is the number of assays.
RESULTS
HCN-1A Cells: Effects of M1 and TransUnoprostone Isopropyl on BK Channel Currents and Plasma Membrane Potential BK channel currents in HCN-1A cells were activated by 10 nM M1 and inhibited by 100 nM of the specific high-affinity BK channel inhibitor, IbTX 39 ( Fig. 1A) . M1 activated these BK channel currents with an EC 50 ¼ 0.61 6 0.06 nM (n ¼ eight cells) (Fig. 1B) , similar to the EC 50 ¼ 0.6 6 0.2 nM (n ¼ six cells) for unoprostone isopropyl previously reported. 4 Transunoprostone isopropyl (10 nM) had no effect (Fig. 1C ). As previously shown for 100 nM unoprostone isopropyl, 4 10 nM unoprostone isopropyl and 10 nM M1 also caused IbTXinhibitable, AL-8810-insensitive plasma membrane hyperpolarization, whereas 10 nM trans-unoprostone isopropyl was not significantly different from the vehicle control (Fig. 1D) . In contrast, 10 nM latanoprost free acid and 10 nM fluprostenol both caused large plasma membrane depolarization that was inhibited by 0.5 lM AL-8810 (Fig. 1D) ] i without and with ET-1
In HTMCs, BK channel currents were activated by 0.5 nM M1 and inhibited by 100 nM IbTX (Figs. 2A, 2B ). BK channel FIGURE 1. HCN1A cells: (A) Effect of M1 on BK channel currents; (B) Dose response of effect of M1 on BK channel currents; (C) Effect of transunoprostone isopropyl, followed by M1 on BK channel current at þ130 mV; (D) Effect of unoprostone isopropyl, M1, trans-unoprostone isopropyl, latanoprost free acid, and fluprostenol on plasma membrane potential. (A) Representative BK channel currents: control, 10 nM M1 followed by 100 nM IbTX and (B) dose response of effect of M1 on BK channel currents (n ¼ 5 cells). EC 50 ¼ 0.61 6 0.06 nM (n ¼ 5 cells). (C) Control BK channel currents at þ130 mV, followed by 10 nM trans-unoprostone isopropyl (trans-uno), then 10 nM M1 followed by 100 nM IbTX (n ¼ 5 cells). *P < 0.0005 wrt control and trans-uno; #P < 0.001 wrt IbTX; ns, not significant wrt control. In (D) plasma membrane potential change was measured with DiBAC 4 (3) after addition of 10 nM unoprostone isopropyl (uno), M1, trans-unoprostone isopropyl (trans-uno), latanoprost free acid (latFA), and fluprostenol (flup). AL-8810 (0.5 lM) was added followed by 1 nM IbTX as indicated. For all compounds, n ¼ 3 coverslips, except for uno where n ¼ 8 coverslips and unoþAL-8810 where n ¼ 4 coverslips. *P < 0.0005, **P < 0.005, #P < 0.02 wrt drug alone. ns, not significant wrt vehicle; NS, not significant wrt drug alone. In (B-D), data are plotted as mean 6 SEM.
currents were activated by M1 with an EC 50 ¼ 0.51 6 0.04 nM (n ¼ six cells) (Fig. 2C) , similar to that measured for HCN-1A cells (Fig. 1B) . Trans-unoprostone isopropyl (10 nM) had no effect (Fig. 2D) . HTMC BK channel currents were also activated by unoprostone isopropyl (Fig. 3A) with an EC 50 ¼ 0.51 6 0.03 (n ¼ five cells), not significantly different from M1 effects or unoprostone isopropyl 4 and M1 (Fig. 1 ) effects in HCN-1A cells. Trans-unoprostone isopropyl, 10 nM, had no effect (Fig. 3B) . Unoprostone isopropyl (10 nM) and 10 nM M1 both caused IbTX-inhibitable, AL-8810-insensitive plasma membrane hyperpolarization (Fig. 3C) , as previously shown for HCN-1A cells, 4 whereas 10 nM trans-unoprostone isopropyl had no effect. In contrast, 10 nM latanoprost free acid and 10 nM fluprostenol both caused plasma membrane depolarization that was inhibited by 0.5 lM AL-8810.
Unoprostone isopropyl and M1 (up to 100 nM) did not increase [cAMP] i significantly above vehicle alone, but latanoprost free acid and fluprostenol caused significant and large increases (Fig. 4A) . Unoprostone isopropyl and M1 significantly decreased [cGMP] i , whereas latanoprost free acid and fluprostenol significantly increased [cGMP] i (Fig. 4B) . Figure 4C shows steady state [Ca 2þ ] i effects in the absence and presence of ET-1. Unoprostone isopropyl (100 nM) and M1 (100 nM) significantly reduced steady state [Ca 2þ ] i (P < 0.01 and P < 0.025, respectively) and 100 nM transunoprostone isopropyl had no effect on steady state [Ca 2þ ] i . ET-1 (1 nM) caused a large steady state [Ca 2þ ] i increase, which was prevented by 100 nM unoprostone isopropyl and 100 nM M1, but not by 100 nM trans-unoprostone isopropyl. In contrast, 100 nM latanoprost free acid and 100 nM fluprostenol both increased steady state [Ca 2þ ] i (P < 0.005 for both), consistent with the findings of others in ciliary muscle 32 and did not prevent ET-1-induced steady state [Ca 2þ ] i increases. ] i was below control values, the effect of 100 nM M1 at 1, 5, and 10 minutes after addition of M1, in the presence and absence of 30 lM AL-8810 on BK channel currents was measured. In Figure 5A , BK channel currents are shown before and after addition of 30 lM AL-8810, followed by 100 nM M1. Current recordings were made at 1, 5, and 10 minutes after M1 addition. Then, 100 nM IbTX was added. Figure 5B shows the summarized data 6 AL-8810. AL-8810 had no effect on the BK channel current and 100 nM M1 caused a large and significant (P < 0.0005) increase in the BK channel current at 1 minute that was maintained over 10 minutes. Subsequent IbTX addition inhibited the current. Parallel experiments were performed without AL-8810, wherein vehicle alone was added. There were no significant differences between HTMC incubated with or without 30 lM AL-8810. 
PASMC: Effects of
cells). (B)
Control BK channel currents at þ130 mV, followed by 10 nM trans-unoprostone isopropyl (trans-uno) and then 10 nM unoprostone isopropyl (uno) followed by 100 nM IbTX (n ¼ 5 cells). *P < 0.001 wrt control, trans-uno, and IbTX. ns, not significant wrt control. In (C), plasma membrane potential change was measured with DiBAC 4 (3) after addition of 10 nM unoprostone isopropyl (uno), M1, transunoprostone isopropyl (trans-uno), latanoprost free acid (latFA), and fluprostenol (flup). AL-8810 (0.5 lM) was then added, followed by 1 nM IbTX as indicated. For all data plotted, n ¼ 3 coverslips except for unoprostone isopropyl where n ¼ 6 coverslips. *P < 0.005, **P < 0.0005, #P < 0.01 wrt drug alone. ns, not significant wrt vehicle; NS, not significant wrt drug alone. In (A-C), data are plotted as mean 6 SEM. [Ca 2þ ] i was measured using indo1/AM before and after treatment with 100 nM drug 6 1 nM ET-1 for 30 minutes (n ¼ 3 coverslips). Drugs: unoprostone isopropyl (uno), M1, trans-unoprostone isopropyl (trans-uno), latanoprost free acid (latFA), and fluprostenol (flup). *P < 0.0005 wrt unoþET-1 & M1þET-1, #P < 0.001 wrt unoþET-1, P < 0.005 wrt M1þET-1. In (A-C), data are plotted as mean 6 SEM. effect (Fig. 6B) . In PASMCs, 10 nM unoprostone isopropyl and 10 nM M1 both caused IbTX-inhibitable, AL-8810-insensitive hyperpolarization (Fig. 6C) . Unoprostone isopropyl decreased steady state [Ca 2þ ] i (P < 0.025), M1 had no effect on steady state [Ca 2þ ] i , and both unoprostone isopropyl and M1 abolished ET-1-induced steady state [Ca 2þ ] i increases (Fig.  6D) . Trans-unoprostone isopropyl (10 nM) had no effect on the plasma membrane potential, [Ca 2þ ] i , or ET-1-induced ] i was reduced by M1 in HTMCs (Fig. 4C ). This is consistent with the findings of others that M1 did not increase steady state [Ca 2þ ] i in HTMCs 8 and that unoprostone isopropyl did not increase steady state [Ca 2þ ] i in HCN-1A cells. 4 However, several studies showed Ca 2þ mobilization (reported as nonratiometric, relative Ca 2þ signals) by M1 in HTMCs, 31 human ciliary muscle cells, 32 and rat A7r5 cells. 33 The time course of Ca 2þ mobilization by M1 was fundamentally different from that caused by other agents. Thus, in A7r5 cells, 33 travoprost free acid, PGF 2a , and bimatoprost acid caused a peak increase in Ca 2þ signal at 15 to 30 seconds and a sustained increase in Ca 2þ , which persisted over the 3-minute time course of the experiments, whereas M1 gave only transient increases in Ca 2þ , which decayed to resting levels or below by 2 to 3 minutes (with no increase in steady state Ca 2þ ). These responses were sensitive to AL-8810. At 10 nM M1, where the BK channel is fully activated, there was only a very small increase in the Ca 2þ signal compared with the highest M1 concentration (3 lM). The largest Ca 2þ signal at 3 lM M1 also decreased to baseline or below within minutes. 33 Similarly, transient AL-8810-sensitive Ca 2þ increases with M1 occurred in HTMCs, 31 although Ca 2þ remained elevated at 10 lM M1 in the single tracing shown. The M1 response in A7r5 cells is similar to that in bradykinin-treated HTMCs in the absence of extracellular Ca 2þ , where Ca 2þ release from intracellular stores gave a transient [Ca 2þ ] i increase from 100 nM to 400 nM, but then fell within 2 to 3 minutes to baseline. 41 This suggests that M1 might cause Ca 2þ release from intracellular Ca 2þ stores, but does not subsequently allow Ca 2þ entry from the extracellular medium through plasma membrane Ca 2þ channels. Shimura et al. 42 reported inhibition of Ca 2þ release-activated Ca 2þ currents at high concentrations of M1 in monkey TMC. Thieme et al. 43 reported inhibition of L-type Ca 2þ channels in HTMCs, over the concentration range of M1 from 1 lM to 100 lM and attributed this in part to plasma membrane hyperpolarization by BK channels. M1 also induced plasma membrane hyperpolarization at the low concentrations used in the present studies (Figs. 1D, 3C, -independent BK channel activation also occurs with a variety of fatty acids and negatively charged lipids. 48 Cymo4, a dehydroabietic acid, activates BK channels in ''the virtual absence of Ca 2þ' '49 and other agents also activate BK channels without [Ca 2þ ] i increases. 50 In addition, an endogenous ancillary protein in nonexcitable cells activates BK channels at resting membrane potential and without Ca 2þ . 51 Genistein, a tyrosine kinase inhibitor, stimulated BK channel currents in bovine TMCs, and this was unaffected by depleting the cells of Ca 2þ . 52 Genistein also inhibited L-type Ca 2þ channels in both bovine and human TMCs. 53 Using cloned human EP [1] [2] [3] [4] and FP receptors, the only activity found was weak agonist activity of M1 on the FP receptor, an EC 50 ¼ 557.2 6 55.2 nM. These results were similar to those found by others using different methods 29, 30 and are approximately 1000 times higher than the EC 50 of 0.52 6 0.03 nM for BK channel activation. The maximal M1 concentration achieved in therapy is approximately 425 6 99 nM 3 . The EC 50 for transient M1-induced Ca 2þ mobilization was 2400 nM in HTMCs, 31 306 nM in rat A7r5 cells, 33 407 nM in mouse Swiss 3T3 cells, 33 and 1270 nM in human embryonic kidney cells expressing cloned human FP receptors. 33 The EC 50 for rat uterus contraction by M1 was 310 nM, 54 and the EC 50 values for M1 binding to bovine corpus luteal homogenate FP receptors, M1-induced phosphoinositol (PI) turnover in a variety of cells, and M1-induced cat and bovine iris contraction were approximately 300 nM to several micromolars in a variety of studies. [31] [32] [33] 54 The EC 50 s were 3280 nM for M1-induced Al-8810-sensitive PI turnover in HTMCs 31 ; 3860 nM for M1 binding to the human cloned FP receptor, 33 and 4192 nM for M1 binding to the cloned human ciliary body FP receptor. 35 Thus the EC 50 for BK channel activation by M1 is very low compared with the various EC 50 values for M1 reported in the above studies. However, the EC 50 for FP receptor activation by M1 in the present study is within the ranges reported by others for a variety of effects.
In FP receptor knockout mice, the IOP lowering effect of unoprostone isopropyl is lost, suggesting that FP receptors are likely involved in IOP lowering. 55 Whatever the role of FP receptor occupation by M1 in IOP lowering, sustained [Ca 2þ ] i increases are not needed for BK channel activation (Fig. 5) . Understanding the mechanism of action of unoprostone isopropyl and M1 in IOP reduction will require an understanding of how BK channels are involved in lowering IOP, and how Control BK channel currents at þ130 mV, followed by 10 nM trans-unoprostone isopropyl (trans-uno) and then 10 nM M1 followed by 100 nM IbTX (n ¼ 6 cells). *P < 0.001 wrt trans-uno and IbTX, #P < 0.005 wrt control. ns, not significant wrt control. (C) Plasma membrane potential change was measured with DiBAC 4 (3) after addition of 10 nM unoprostone isopropyl (uno), M1, transunoprostone isopropyl (trans-uno), latanoprost free acid (latFA), and fluprostenol (flup). AL-8810 (0.5 lM) was added followed by 1 nM IbTX as indicated. For all compounds, n ¼ 3 coverslips. *P < 0.005, #P < 0.01 wrt drug alone. ns, not significant wrt vehicle; NS, not significant wrt drug alone. (D) Steady state [Ca 2þ ] i was measured using indo1/AM before and after treatment with drug 6 1 nM ET-1 for 30 minutes (n ¼ 3 coverslips). Drugs: 100 nM unoprostone isopropyl (uno), M1, trans-unoprostone isopropyl (trans-uno), latanoprost free acid (latFA), and fluprostenol (flup). *P < 0.01 wrt unoþET-1 and P < 0.025 wrt M1þET-1, #P < 0.001 wrt unoþET-1 and P < 0.0005 wrt M1þET-1; **P < 0.0005 wrt unoþET-1 and M1þET-1; ##P < 0.001 wrt unoþET-1 and P < 0.0005 wrt M1þET-1. In (A-D) , data are plotted as mean 6 SEM. and Schlemm's canal cells, 56 and are involved in outflow facility and decreasing trabecular meshwork cell volume. 8, 9, 57 In the present study, BK channels in HTMCs were activated by unoprostone isopropyl and M1 with similar EC 50 s of 0.5 nM. Treatment of trabecular meshwork with unoprostone isopropyl has been previously shown to inhibit ET-1-induced contractility, likely contributing to IOP lowering by increasing aqueous outflow. 8 It is of interest that glaucomatous TMCs exhibit mitochondrial defects wherein the cells are abnormally sensitive to Ca 2þ stress and thus Ca 2þ regulation dysfunction may contribute to the inability to control IOP. 58 BK channel activation has also been shown to cause dilation of ET-1-treated retinal arterioles, resulting in increased blood flow. 59 In the present study, PASMCs also exhibited unoprostone isopropyl and M1-stimulated BK channels. BK channels also modulate pre-and postsynaptic signaling at reciprocal synapses in retina 60 and are involved in receptor potential regulation of rod receptors. 61 BK channel activation could be responsible not only for increased blood flow in the eye 22 and ocular outflow facility, 23 as it results in membrane hyperpolarization and Ca 2þ entry is prevented, which could lead to smooth muscle relaxation, but also for neuroprotective effects seen in patients with glaucoma 19, 20 and retinitis pigmentosa (Yamamoto S, et al. been shown to reduce oxidative stress-and light-induced damage in the human retinal pigment epithelial cell line, and this effect is mediated by BK channels, as it is inhibited by IbTX. 62 These findings support the view that BK channel activators are neuroprotective agents. 63, 64 The present findings show that at the concentrations used (up to 100 nM), effects of the prostones, unoprostone isopropyl, and M1, were similar in neuronal, ocular trabecular meshwork and smooth muscle cells and provide insight into the molecular and cellular effects and mechanism of action of unoprostone isopropyl and its primary metabolite M1. These findings also provide additional insight that may help explain/understand published clinical findings. 12, [19] [20] [21] [22] These findings confirm and extend our previous findings that unoprostone isopropyl activates BK channels in HCN-1A cells. Together, these findings may provide a rationale for understanding unoprostone isopropyl's efficacy in the treatment of glaucoma.
